{"id":62674,"date":"2026-02-19T22:05:59","date_gmt":"2026-02-19T21:05:59","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\/"},"modified":"2026-02-19T22:05:59","modified_gmt":"2026-02-19T21:05:59","slug":"definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\/","title":{"rendered":"Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026"},"content":{"rendered":"
\n

NEW YORK–(BUSINESS WIRE)–Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.), (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it will host a live webcast at 4:30 p.m. EST on Thursday, February 26, 2026 to report financial results for the full year ended December 31, 2025, and discuss recent business updates.<\/p>\n

<\/a>
<\/a><\/p>\n

\nListeners can register for the webcast via this link<\/a>. Analysts wishing to participate in the question and answer session should use this link<\/a>. A replay of the webcast will be available via the Investor Relations section of the Definium Therapeutics website, ir.definiumtx.com<\/a>, and archived for at least 30 days after the webcast. Those who plan on participating are advised to join 15 minutes prior to the start time.<\/p>\n

\nAbout Definium Therapeutics
\n
<\/b>The mission of Definium Therapeutics is to forge a new era of psychiatry by applying scientific rigor to psychedelics, with the goal of developing accessible treatments that unlock healing at scale. Guided by a recognition that patients deserve more than better, Definium is relentlessly advancing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders. By turning evidence into impact, Definium aims to change the trajectory of today\u2019s mental health care crisis and enable a healthier future. Headquartered in New York, Definium Therapeutics trades on Nasdaq under the symbol DFTX.<\/p>\n

\nFor more information, visit https:\/\/definiumtx.com\/<\/a> and follow Definium Therapeutics on Instagram<\/a>, LinkedIn<\/a> and X<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Contact:<\/b>
Gitanjali Jain
\n
VP, Head of Investor Relations
\n
IR@definiumtx.com<\/a><\/p>\n

\nMedia Contact:<\/b>
media@definiumtx.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK–(BUSINESS WIRE)–Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.), (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it will host a live webcast at 4:30 p.m. EST on Thursday, February 26, 2026 to report financial results … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62674","6":"format-standard","7":"category-industry"},"yoast_head":"\nDefinium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NEW YORK–(BUSINESS WIRE)–Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.), (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it will host a live webcast at 4:30 p.m. EST on Thursday, February 26, 2026 to report financial results ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-19T21:05:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260219692160\/en\/2725333\/22\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026\",\"datePublished\":\"2026-02-19T21:05:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\\\/\"},\"wordCount\":277,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260219692160\\\/en\\\/2725333\\\/22\\\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\\\/\",\"name\":\"Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260219692160\\\/en\\\/2725333\\\/22\\\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg\",\"datePublished\":\"2026-02-19T21:05:59+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260219692160\\\/en\\\/2725333\\\/22\\\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260219692160\\\/en\\\/2725333\\\/22\\\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\/","og_locale":"en_US","og_type":"article","og_title":"Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026 - Pharma Trend","og_description":"NEW YORK–(BUSINESS WIRE)–Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.), (NASDAQ: DFTX), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorders, today announced that it will host a live webcast at 4:30 p.m. EST on Thursday, February 26, 2026 to report financial results ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\/","og_site_name":"Pharma Trend","article_published_time":"2026-02-19T21:05:59+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260219692160\/en\/2725333\/22\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026","datePublished":"2026-02-19T21:05:59+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\/"},"wordCount":277,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260219692160\/en\/2725333\/22\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\/","url":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\/","name":"Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260219692160\/en\/2725333\/22\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg","datePublished":"2026-02-19T21:05:59+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260219692160\/en\/2725333\/22\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260219692160\/en\/2725333\/22\/Definium_Logo_Therapeutics_Lockup_RGB_Black_Orange.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/definium-therapeutics-to-report-full-year-2025-financial-results-on-february-26-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Definium Therapeutics to Report Full Year 2025 Financial Results on February 26, 2026"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62674","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62674"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62674\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62674"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62674"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62674"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}